However, pharmacological inhibition of SHP-2 using SHP099 did not influence MG-induced pro-inflammatory cytokine release (Supplementary Figure S4E–G), indicating that SHP-2 does not play an active role in inducing inflammation mediated by MG. Here, PTPN11 is linked to myasthenia gravis.